International Women’s Day – MIND THE GAP: Closing the gender gaps in life scie...
Read more >
Featured Insights: Biotechnology & Pharmaceuticals
RADIOTHERAPY: The Patent Landscape
Read more >
Sustainable Future: Exploring innovations for the Energy Transition and Circular Economy
Read more >
The Plausibility Saga Continues: Post-filed evidence at the EPO
Read more >
The Drug Exclusivity Landscape in Europe
Read more >
Brazil, it’s just like watching Brazil
Read more >
Patenting MedTech Simulations
Read more >
COVID-19 and the Rapid Rise of Genetic Sequencing
Read more >
Supplementary Protection Certificates (SPCs): Could the EU/UK trade deal have an impact o...
Read more >
China’s new patent law – important changes for the pharmaceutical sector
Read more >
Supplementary Protection Certificates (SPCs): How will the border solution between Irelan...
Read more >
Regeneron v Kymab – Principles capable of general application
Read more >
Seeing Article 3(d) with 2020 vision – revisited
Read more >
Regeneron v Kymab – Sufficiency explained through transgenic mice and teleporters
Read more >
The End of (Interrupted) Days is Nigh
Read more >
The slow death of Neurim – will SPCs for new indications soon be a thing of the past...
Read more >
Interpreting Article 3(a) of supplementary protection certificates (SPCs) regulation with ...
Read more >
A fight against time: Coronavirus vs Biotechnology
Read more >
Artificial intelligence and antibiotics: overcoming excluded subject-matter hurdles
Read more >
A Whistlestop Guide to SPCs
Read more >